The Israel Innovation Authority (IIA) approved NIS 22 million (approximately $6 million) in grants last week for 35 startups and companies trying to combat issues caused by the coronavirus pandemic.

On March 17, the IIA, Israel’s Ministry of Health and the Ministry for Social Equality announced the allocation of NIS 50 million (approximately $13 million) in grants to companies “submitting research and development plans, proofs-of-concept, products and technological solutions that address the challenges of the coronavirus pandemic,” Calcalist reported.

“Among the companies that received the grants were NEAT Applied Technologies Ltd., which produces sensors and remote monitoring solutions that can help with the managing of flow, pressure and volume of patients; Ezmems Ltd., which develops smart plastic sensors for ventilators; and NanoScent Ltd., which offers a scent-recognition service that can help detect people with coronavirus symptoms.”

Ami Appelbaum, IIA chairman of the board and chief scientist at the Ministry of Economics and Industry, said “the committee chose to support a wide range of projects dealing with the challenges of coronavirus because the fight against the pandemic needs to be waged on multiple fronts.”

He added that “a strong emphasis has been put on the proposals that can combat the crisis immediately with a quick time to market or promising partnerships that will ensure the functional continuity of the Israeli economy.”

Appelbaum’s team received more than 750 applications from companies. Additional grants are expected to be approved next week.

Support Jewish Journalism
with 2020 Vision

One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.

JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.

During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.

Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.